Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma. [electronic resource]
Producer: 20100927Description: 1203-1210 p. digitalISSN:- 1569-8041
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Agents -- administration & dosage
- Combined Modality Therapy
- Drug Administration Schedule
- Female
- Humans
- Immune System -- physiology
- Immunotherapy
- Lymphoma -- immunology
- Lymphoma, Mantle-Cell -- immunology
- Male
- Middle Aged
- Neoplasm Staging
- Recovery of Function -- immunology
- Rituximab
- Stem Cell Transplantation -- methods
- Transplantation Immunology
- Transplantation, Autologous
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.